Texture analysis of (125)I-A5B7 anti-CEA antibody SPECT differentiates metastatic colorectal cancer model phenotypes and anti-vascular therapy response.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Works matching IS 00070920 AND DT 2015 AND VI 112 AND IP 12
Results: 23
1
2
Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1895, doi. 10.1038/bjc.2015.163
- By:
- Publication type:
- Article
3
Comment on: 'Vitamin D supplements and cancer incidence and mortality: a meta-analysis'.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1979, doi. 10.1038/bjc.2015.118
- By:
- Publication type:
- Article
4
Long-term adverse outcomes in survivors of childhood bone sarcoma: the British Childhood Cancer Survivor Study.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1857, doi. 10.1038/bjc.2015.159
- By:
- Publication type:
- Article
5
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1874, doi. 10.1038/bjc.2015.144
- By:
- Publication type:
- Article
6
Response to Comment on: 'Evaluation of chemoresponse assays as predictive biomarkers'.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1978, doi. 10.1038/bjc.2015.157
- By:
- Publication type:
- Article
7
Texture analysis of <sup>125</sup>I-A5B7 anti-CEA antibody SPECT differentiates metastatic colorectal cancer model phenotypes and anti-vascular therapy response.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1882, doi. 10.1038/bjc.2015.166
- By:
- Publication type:
- Article
8
Comment on: 'Vitamin D supplements and cancer incidence and mortality: a meta-analysis'.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1979, doi. 10.1038/bjc.2015.117
- By:
- Publication type:
- Article
9
NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1958, doi. 10.1038/bjc.2015.121
- By:
- Publication type:
- Article
10
Case-control study of Epstein-Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1866, doi. 10.1038/bjc.2015.175
- By:
- Publication type:
- Article
11
Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1911, doi. 10.1038/bjc.2015.92
- By:
- Publication type:
- Article
12
Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1944, doi. 10.1038/bjc.2015.177
- By:
- Publication type:
- Article
13
Referee Acknowledgement for 2014.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1981, doi. 10.1038/bjc.2015.210
- Publication type:
- Article
14
KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1929, doi. 10.1038/bjc.2015.165
- By:
- Publication type:
- Article
15
The prioritisation of paediatrics and palliative care in cancer control plans in Africa.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1845, doi. 10.1038/bjc.2015.158
- By:
- Publication type:
- Article
16
PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1938, doi. 10.1038/bjc.2015.169
- By:
- Publication type:
- Article
17
Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1951, doi. 10.1038/bjc.2015.95
- By:
- Publication type:
- Article
18
Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1966, doi. 10.1038/bjc.2015.160
- By:
- Publication type:
- Article
19
Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1904, doi. 10.1038/bjc.2015.180
- By:
- Publication type:
- Article
20
Comment on: 'Guidelines for the use of cell lines in biomedical research': human-to-human cancer transmission as a laboratory safety concern.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1976, doi. 10.1038/bjc.2014.656
- By:
- Publication type:
- Article
21
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1921, doi. 10.1038/bjc.2015.142
- By:
- Publication type:
- Article
22
Comment on: 'Evaluation of chemoresponse assays as predictive markers'.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1977, doi. 10.1038/bjc.2015.156
- By:
- Publication type:
- Article
23
Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1888, doi. 10.1038/bjc.2015.173
- By:
- Publication type:
- Article